Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

RepID as a potential biomarker and therapeutic target for lung neuroendocrine tumor

Scientific Reports(2024)10.1038/s41598-024-79104-9Source: DataRank Database

RepID as a potential biomarker and therapeutic target for lung neuroendocrine tumor is a research paper published in Scientific Reports (2024). On theSindex it has a DataRank of 0.208. It has been cited 3 times.

N/A

0.208DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.53)OA: goldTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.208

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (8)

Jae-Hyun Jo ORCID,Sangjune Kim ORCID,Christophe E. Redon ORCID,Mirit I. Aladjem ORCID,Yuri Seo ORCID

Live enrichment

PubMed:39523440 PMC:PMC11551140 OpenAlex:https://openalex.org/W4404217292

National Research Foundation of Korea

Grant: 2021RIS-001

National Institutes of Health

Grant: 1ZIABC010411 to MIA

National Institutes of Health

Grant: 1ZIABC010411-19

Initiation of DNA Replication in Mammalian Cells

FWCI

0.53

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1038/s41598-024-79104-9

GOLDhttps://doi.org/10.1038/s41598-024-79104-9

publisherhttps://doi.org/10.1038/s41598-024-79104-9

publisherhttps://www.nature.com/articles/s41598-024-79104-9.pdf

publisherhttps://www.nature.com/articles/s41598-024-79104-9

Fields of Study

Lung Cancer Research StudiesNeuroendocrine Tumor Research AdvancesNeuroblastoma Research and TreatmentsMedicineBiology0301 basic medicine0303 health sciences03 medical and health sciencesHumansLung NeoplasmsBiomarkers, TumorNeuroendocrine TumorsCell Line, TumorSmall Cell Lung CarcinomaGene Expression Regulation, NeoplasticAntineoplastic Agents

MeSH Terms

Antineoplastic AgentsHumansLung NeoplasmsBiomarkers, TumorGene Expression Regulation, NeoplasticNeuroendocrine TumorsCell Line, TumorSmall Cell Lung Carcinoma

Keywords

BiomarkerLungMedicineComputational biologyBioinformaticsLung cancerOncologyCancer researchInternal medicineBiologyGeneticssmall cell lung cancerNeuroendocrine TumorCrlRepidLung NeoplasmsScienceQRAntineoplastic AgentsSmall Cell Lung CarcinomaArticleGene Expression Regulation, NeoplasticNeuroendocrine TumorsCell Line, TumorBiomarkers, TumorHumans

Sustainable Development Goals

SDG 0: Good health and well-being

RepID as a potential biomarker and therapeutic target for lung neuroendocrine tumor

FAIR Checklist

DataRank Breakdown

Authors (8)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)